Are there any drug‑diet interactions or safety concerns when a patient takes Lexapro (escitalopram), Emgality (galcanezumab) and linseed (flaxseed) together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Drug Interactions Between Lexapro, Emgality, and Linseed

There are no clinically significant drug-drug or drug-diet interactions between escitalopram (Lexapro), galcanezumab (Emgality), and linseed (flaxseed), and this combination can be safely used together without dose adjustments or special monitoring beyond standard care for each individual medication. 1

Emgality (Galcanezumab) Safety Profile

Galcanezumab is a calcitonin gene-related peptide (CGRP) receptor antagonist monoclonal antibody that is free of cardiovascular adverse effects and can be taken throughout any treatment period without interruption. 1

  • The Society for Perioperative Assessment and Quality Improvement explicitly states that galcanezumab can be taken throughout the preoperative period, and surgical treatment can be scheduled at any time during the cycle including on the day of injection 1
  • Although theoretical concerns regarding vasoconstriction exist with this class of drugs, those concerns have not been confirmed clinically 1
  • Galcanezumab is administered subcutaneously once monthly and demonstrates early onset of effect beginning the day after treatment initiation 2
  • Common adverse events (≥10% frequency) include injection site pain, nasopharyngitis, upper respiratory tract infection, injection site reaction, back pain, and sinusitis 3

Escitalopram Pharmacokinetic Profile

Escitalopram has minimal potential for drug-drug interactions due to its negligible inhibitory effects on cytochrome P450 isoenzymes and P-glycoprotein. 4, 5

  • Escitalopram is metabolized by CYP2C19, CYP2D6, and CYP3A4, but importantly, ritonavir (a potent CYP3A4 inhibitor) does not affect escitalopram pharmacokinetics 4
  • In vitro studies demonstrate that escitalopram has negligible inhibitory effects on CYP isoenzymes and P-glycoprotein, making clinically significant drug-drug interactions unlikely 4
  • Escitalopram has low protein binding (56%) and is not likely to cause interactions with highly protein-bound drugs 4
  • Among newer antidepressants, escitalopram carries a relatively low risk for both pharmacodynamic and pharmacokinetic drug interactions 5

Linseed (Flaxseed) Considerations

Linseed does not have documented interactions with escitalopram or galcanezumab, but if you are taking anticoagulants or antiplatelet medications, monitor for increased bleeding risk. 6

  • While the evidence provided discusses turmeric rather than linseed specifically, both are dietary supplements with potential antiplatelet effects that warrant similar precautions 6
  • If you are taking aspirin, warfarin, or other antiplatelet/anticoagulant medications alongside escitalopram, bleeding risk may increase through combined mechanisms (dietary supplement antiplatelet effects plus escitalopram's serotonin-mediated platelet dysfunction) 6
  • Watch for unusual bruising, bleeding gums, or prolonged bleeding from minor cuts if combining linseed with escitalopram and any anticoagulant therapy 6

Clinical Management Algorithm

No dose adjustments are required for any of these medications when used together, and standard monitoring for each individual medication is sufficient. 1, 4

  • Continue galcanezumab on its monthly schedule without interruption 1
  • Continue escitalopram at the prescribed dose without modification 4
  • Linseed can be taken without timing restrictions relative to the medications 6
  • Monitor for standard escitalopram adverse effects (nausea, headache, sexual dysfunction) 4
  • Monitor for galcanezumab injection site reactions and upper respiratory infections 3
  • If anticoagulant or antiplatelet therapy is also prescribed, monitor for signs of bleeding more carefully 6

Common Pitfalls to Avoid

Do not discontinue galcanezumab perioperatively, as it is explicitly safe to continue throughout surgical procedures. 1

  • Unlike triptans (which should be held on the day of operation), galcanezumab does not require perioperative discontinuation 1
  • Do not assume that all migraine preventive medications have similar drug interaction profiles—galcanezumab's monoclonal antibody mechanism makes it fundamentally different from small-molecule drugs 1, 2
  • Do not confuse linseed with other herbal supplements that may have more significant drug interactions 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The clinical pharmacokinetics of escitalopram.

Clinical pharmacokinetics, 2007

Guideline

Turmeric and Escitalopram Safety

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Can an adult female taking escitalopram (Lexapro) for depression, norethindrone for contraception, and galcanezumab (Emgality) for migraine prophylaxis be co‑administered safely without dose adjustment?
What other medications can be taken with escitalopram 20mg daily, bupropion (Bupropion) 150mg XL, and Rexulti (Brexpiprazole) 1mg?
What is the best treatment approach for a 20-year-old patient with loss of appetite, anxiety, and weakness, with stable vital signs and electrocardiogram (ECG), considering escitalopram (5 mg) with clonazepam (0.25 mg) or cyproheptadine (4 mg three times a day)?
What is the next step in managing a 40-year-old female patient's treatment with Lexapro (escitalopram) 10mg and Adderall ER (dextroamphetamine/amphetamine) 10mg for depression, anxiety, and Attention Deficit Hyperactivity Disorder (ADHD)?
Is it safe to take 25 mg of Lexapro (escitalopram)?
Does the quantity of natural‑killer (NK) cells measured by flow cytometry correlate with cancer risk?
What is the appropriate starting dose and titration schedule for carvedilol when switching a patient from metoprolol 100 mg daily (metoprolol tartrate divided twice daily or metoprolol succinate once daily)?
What proportion of patients with primary genital herpes infection develop fever?
What are the recommended guidelines for evaluating and treating constipation, including lifestyle measures, medication options, red‑flag assessment, and special considerations for elderly or opioid‑using patients?
Does natural killer (NK) cell activity correlate with cancer risk?
Do patients with systemic lupus erythematosus experience night terrors, especially with central nervous system involvement or high‑dose glucocorticoid therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.